The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis-Reference-Cited by-同舟云学术

The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis

Published:2015-09-25 Issue:suppl 3 Volume:61 Page:S147-S154
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clin Infect Dis.

Author:

Knight Gwenan M.,Colijn Caroline,Shrestha Sourya,Fofana Mariam,Cobelens Frank,White Richard G.,Dowdy David W.,Cohen Ted

Funder

Bill & Melinda Gates Foundation

Medical Research Council (UK)

Aurum Institute

Engineering and Physical Sciences Research Council

Medical Scientist Training Program

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/61/suppl_3/S147/17352582/civ579.pdf

Reference41 articles.

1. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010

2. World Health Organization. Global tuberculosis report. Geneva, Switzerland: WHO, 2014.

3. Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: a theoretical framework

4. Control Strategies for Tuberculosis Epidemics: New Models for Old Problems

5. Criteria for the control of drug-resistant tuberculosis

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review;PLOS Pathogens;2024-04-10

2. Genomic analysis of Lineage specific Transmission of multidrug resistance tuberculosis in China;Emerging Microbes & Infections;2023-12-21

3. An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management;Pharmaceuticals;2023-04-12

4. The relative transmission fitness of multidrug-resistant Mycobacterium tuberculosis in a drug resistance hotspot;Nature Communications;2023-04-08

5. Mycobacterium tuberculosis Transmission in High-Incidence Settings—New Paradigms and Insights;Pathogens;2022-10-25